A carregar...

Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice

To address complications of pathogenic antibody or life-threatening anaphylactic reactions in protein replacement therapy for patients with hemophilia or other inherited protein deficiencies, we have developed a prophylactic protocol using a murine hemophilia B model. Oral delivery of coagulation fa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Verma, Dheeraj, Moghimi, Babak, LoDuca, Paul A., Singh, Harminder D., Hoffman, Brad E., Herzog, Roland W., Daniell, Henry
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2872434/
https://ncbi.nlm.nih.gov/pubmed/20351275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0912181107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!